Gene: CPSF7
Official Full Name: cleavage and polyadenylation specific factor 7provided by HGNC
Gene Summary: Cleavage factor Im (CFIm) is one of six factors necessary for correct cleavage and polyadenylation of pre-mRNAs. CFIm is composed of three different subunits of 25, 59, and 68 kDa, and it functions as a heterotetramer, with a dimer of the 25 kDa subunit binding to two of the 59 or 68 kDa subunits. The protein encoded by this gene represents the 59 kDa subunit, which can interact with the splicing factor U2 snRNP Auxiliary Factor (U2AF) 65 to link the splicing and polyadenylation complexes. [provided by RefSeq, Oct 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20147 | CPSF7 Knockout cell line (HeLa) | Human | CPSF7 | 1:3~1:6 | Negative | Online Inquiry |
KO20148 | CPSF7 Knockout cell line (HCT 116) | Human | CPSF7 | 1:2~1:4 | Negative | Online Inquiry |
KO20149 | CPSF7 Knockout cell line (HEK293) | Human | CPSF7 | 1:3~1:6 | Negative | Online Inquiry |
KO20150 | CPSF7 Knockout cell line (A549) | Human | CPSF7 | 1:3~1:4 | Negative | Online Inquiry |
CPSF7 Gene Knockout Cell Lines are engineered cellular models that lack the expression of the CPSF7 gene, which is crucial in the process of pre-mRNA 3' end processing. These cell lines serve as an invaluable tool for researchers seeking to elucidate the role of CPSF7 in gene expression regulation, mRNA maturation, and subsequent downstream effects on cellular function. By specifically disrupting the CPSF7 gene, these knockout models allow for a clearer investigation of the gene’s contributions to various biological pathways.
The key function of CPSF7 revolves around its role as a component of a multiprotein complex that facilitates cleavage and polyadenylation of pre-mRNA, a critical step in mRNA processing. The absence of CPSF7 in these knockout lines leads to aberrant pre-mRNA processing, resulting in altered profiles of gene expression. Researchers can utilize these models to study molecular mechanisms underpinning diseases linked to disrupted mRNA processing and to explore potential therapeutic targets in pathologies such as cancer and neurodegenerative disorders.
In clinical and research settings, CPSF7 Gene Knockout Cell Lines are significant for their potential applications in drug discovery, genetic studies, and the development of novel gene therapies. Their unique ability to mimic the loss-of-function scenarios in human cells provides a reliable context for evaluating therapeutic interventions and understanding disease mechanisms.
Compared to traditional models, CPSF7 knockout cell lines offer the advantage of specificity and precision in dissecting the effects of the CPSF7 gene itself, reducing the variability often seen in less targeted systems. By eliminating confounding factors inherent in wild-type cells, researchers can achieve more reliable and reproducible data that inform hypothesis-driven investigations.
For researchers and clinicians dedicated to advancing the understanding of gene regulation and its implications in health and disease, CPSF7 Gene Knockout Cell Lines present a powerful resource. Our company specializes in providing high-quality biological products backed by rigorous scientific validation. With our expertise in gene editing technologies and cell line development, we are committed to supporting the scientific community in their quest for innovative solutions and breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.